Ian J Sarembock
Overview
Explore the profile of Ian J Sarembock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lerakis S, Kini A, Giustino G, Anastasius M, Asch F, Weissman N, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(5):101345.
PMID: 39132458
Background: Transcatheter edge-to-edge repair (TEER) improved outcomes in patients with heart failure (HF) and severe secondary mitral regurgitation (SMR) compared with guideline-directed medical therapy (GDMT) alone regardless of the severity...
2.
Stone G, Abraham W, Lindenfeld J, Kar S, Grayburn P, Lim D, et al.
N Engl J Med
. 2023 Mar;
388(22):2037-2048.
PMID: 36876756
Background: Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge repair of severe mitral regurgitation, as compared with outcomes after maximal doses of guideline-directed medical therapy alone, in patients...
3.
Kosmidou I, Lindenfeld J, Abraham W, Rinaldi M, Kapadia S, Rajagopal V, et al.
JACC Heart Fail
. 2021 Aug;
9(9):674-683.
PMID: 34391744
Objectives: This study sought to assess the sex-specific outcomes in patients with heart failure (HF) with 3+ and 4+ secondary mitral regurgitation (SMR) treated with transcatheter mitral valve repair (TMVr)...
4.
Lim D, Smith R, Zahr F, Dhoble A, Laham R, Lazkani M, et al.
Catheter Cardiovasc Interv
. 2021 May;
98(4):E637-E646.
PMID: 34004077
Objectives: We report the 30-day outcomes from the roll-in cohort of the CLASP IID trial, representing the first procedures performed by each site. Background: The currently enrolling CLASP IID/IIF pivotal...
5.
Mack M, Lindenfeld J, Abraham W, Kar S, Lim D, Mishell J, et al.
J Am Coll Cardiol
. 2021 Feb;
77(8):1029-1040.
PMID: 33632476
Background: In the COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial, transcatheter mitral valve repair (TMVr) resulted in fewer heart...
6.
Lerakis S, Kini A, Asch F, Kar S, Lim D, Mishell J, et al.
EuroIntervention
. 2021 Feb;
17(4):e335-e342.
PMID: 33589408
Background: In the COAPT trial, transcatheter mitral valve repair with the MitraClip plus maximally tolerated guideline-directed medical therapy (GDMT) improved clinical outcomes compared with GDMT alone in symptomatic patients with...
7.
Truong V, Mazur W, Broderick J, Egnaczyk G, Kereiakes D, Sarembock I, et al.
J Am Soc Echocardiogr
. 2020 Aug;
33(11):1357-1362.e2.
PMID: 32828622
Background: The aim of this study was to examine the relationship between baseline left ventricular (LV) geometry and outcomes after transcatheter aortic valve replacement (TAVR). Methods: Patients undergoing TAVR (n ...
8.
Shreenivas S, Choo J, Answini G, Sarembock I, Griffin J, Smith J, et al.
JACC Cardiovasc Interv
. 2020 Jul;
13(13):1605-1606.
PMID: 32646703
No abstract available.
9.
Arashi H, Kobayashi Y, Price M, Nishi T, Chambers J, Seto A, et al.
JACC Cardiovasc Interv
. 2020 May;
13(10):1272-1275.
PMID: 32439000
No abstract available.
10.
Kereiakes D, Windecker S, Jobe R, Mehta S, Sarembock I, Feldman R, et al.
Circ Cardiovasc Interv
. 2019 Aug;
12(9):e008152.
PMID: 31451014
Background: The thin-strut SYNERGY stent has an abluminal everolimus-eluting bioabsorbable polymer coating designed to facilitate vascular healing and reduce risk of stent thrombosis. In the multicenter, randomized EVOLVE II trial...